Galenica : Investor Presentation (Version août 2023; en anglais)
August 08, 2023 at 10:43 am IST
Share
Investor Presentation
Galenica Group
August 2023
Investor Presentation Galenica Group
Table of contents
About Galenica
page 03
Market environment
page 33
Business performance
page 43
Governance
page 64
Sustainability
page 75
Outlook
page 84
August 23
Investor Presentation Galenica Group
2
About Galenica
Investor Presentation Galenica Group
Galenica in figures
Net sales1
EBIT adjusted1,2
Galenica Group
Galenica Group
24%
CHF 41%
CHF
3,588.5
190.6
59% million
million
76%
Products & Care
Logistics & IT
Products & Care
Logistics & IT
2022 adjusted due to presentation of Mediservice as discontinued operations following joint venture with Redcare Pharmacy N.V.
Adjusted EBIT, excludes IAS 19 and IFRS 16 effects
Leading healthcare provider in Switzerland
369
own pharmacies
Employees (Headcount)
> 7,600
Dividend yield
2.9%
August 23
Investor Presentation Galenica Group
4
Building the leading Swiss healthcare platform
Joint Venture
2000 2002
Creation of Amavita uniform brand in Switzerland
2005 2007
Opening of highly automated distribution centre in Niederbipp
2008 2009
Acquisition
2013
Organic and acquisition-led expansion of pharmacies network
Acquisition
Acquisition
Acquisition
Segment Products & Care
Segment Logistics & IT
August 23
Investor Presentation Galenica Group
5
Attachments
Original Link
Original Document
Permalink
Disclaimer
Galenica AG published this content on 08 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 August 2023 05:12:45 UTC.
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
GALENICA AG 
